While TKIs primarily target VEGF/VEGFR signaling to inhibit tumor angiogenesis, prolonged drug exposure can lead to the activation of alternative pro-survival signaling cascades that allow tumor cells to evade VEGF inhibition. The gene discussed is KDR; the disease is neoplasm.